256 related articles for article (PubMed ID: 16785538)
1. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function.
Pecora ND; Gehring AJ; Canaday DH; Boom WH; Harding CV
J Immunol; 2006 Jul; 177(1):422-9. PubMed ID: 16785538
[TBL] [Abstract][Full Text] [Related]
2. TLR2 and its co-receptors determine responses of macrophages and dendritic cells to lipoproteins of Mycobacterium tuberculosis.
Drage MG; Pecora ND; Hise AG; Febbraio M; Silverstein RL; Golenbock DT; Boom WH; Harding CV
Cell Immunol; 2009; 258(1):29-37. PubMed ID: 19362712
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Lipoprotein Rv1016c Derived from
Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
[TBL] [Abstract][Full Text] [Related]
4. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
7. Recombinant MPT83 derived from Mycobacterium tuberculosis induces cytokine production and upregulates the function of mouse macrophages through TLR2.
Chen ST; Li JY; Zhang Y; Gao X; Cai H
J Immunol; 2012 Jan; 188(2):668-77. PubMed ID: 22174456
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2.
Drage MG; Tsai HC; Pecora ND; Cheng TY; Arida AR; Shukla S; Rojas RE; Seshadri C; Moody DB; Boom WH; Sacchettini JC; Harding CV
Nat Struct Mol Biol; 2010 Sep; 17(9):1088-95. PubMed ID: 20694006
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2.
Banaiee N; Kincaid EZ; Buchwald U; Jacobs WR; Ernst JD
J Immunol; 2006 Mar; 176(5):3019-27. PubMed ID: 16493060
[TBL] [Abstract][Full Text] [Related]
10. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
11. PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2.
Xu Y; Yang E; Huang Q; Ni W; Kong C; Liu G; Li G; Su H; Wang H
J Mol Med (Berl); 2015 Jun; 93(6):645-62. PubMed ID: 25586105
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
13. A subunit vaccine based on rH-NS induces protection against Mycobacterium tuberculosis infection by inducing the Th1 immune response and activating macrophages.
Liu Y; Chen S; Pan B; Guan Z; Yang Z; Duan L; Cai H
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):909-922. PubMed ID: 27563010
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling.
Pennini ME; Pai RK; Schultz DC; Boom WH; Harding CV
J Immunol; 2006 Apr; 176(7):4323-30. PubMed ID: 16547269
[TBL] [Abstract][Full Text] [Related]
15. The rLrp of Mycobacterium tuberculosis inhibits proinflammatory cytokine production and downregulates APC function in mouse macrophages via a TLR2-mediated PI3K/Akt pathway activation-dependent mechanism.
Liu Y; Li JY; Chen ST; Huang HR; Cai H
Cell Mol Immunol; 2016 Nov; 13(6):729-746. PubMed ID: 26166760
[TBL] [Abstract][Full Text] [Related]
16. LpqT improves mycobacteria survival in macrophages by inhibiting TLR2 mediated inflammatory cytokine expression and cell apoptosis.
Li F; Feng L; Jin C; Wu X; Fan L; Xiong S; Dong Y
Tuberculosis (Edinb); 2018 Jul; 111():57-66. PubMed ID: 30029916
[TBL] [Abstract][Full Text] [Related]
17. PPE26 induces TLR2-dependent activation of macrophages and drives Th1-type T-cell immunity by triggering the cross-talk of multiple pathways involved in the host response.
Su H; Kong C; Zhu L; Huang Q; Luo L; Wang H; Xu Y
Oncotarget; 2015 Nov; 6(36):38517-37. PubMed ID: 26439698
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.
Shukla S; Richardson ET; Drage MG; Boom WH; Harding CV
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30037791
[No Abstract] [Full Text] [Related]
19. Mycobacterium tuberculosis 19-kDa lipoprotein induces Toll-like receptor 2-dependent peroxisome proliferator-activated receptor γ expression and promotes inflammatory responses in human macrophages.
Liu L; Liu J; Niu G; Xu Q; Chen Q
Mol Med Rep; 2015 Apr; 11(4):2921-6. PubMed ID: 25504154
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.
Gehring AJ; Dobos KM; Belisle JT; Harding CV; Boom WH
J Immunol; 2004 Aug; 173(4):2660-8. PubMed ID: 15294983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
